PeruBefore committing capital to Peru's growing medical devices market, Taevas Global equips manufacturers with the regulatory, competitive, and commercial intelligence needed to enter with confidence. From DIGEMID registration requirements to hospital procur
Our research framework covers every dimension a medical devices manufacturer needs to make a sound, evidence-based decision about entering or expanding in Peru.
We map the full DIGEMID registration pathway for medical devices in Peru, including device classification under Supreme Decree 016-2011-SA, required technical dossier components, and realistic approval timelines. You receive a step-by-step regulatory roadmap before you engage a local distributor or file a single document.
Our four-stage engagement is designed to move from your initial brief to a fully validated, decision-ready intelligence report within six weeks.
We begin with a structured intake session to understand your device category, intended end-users, existing regulatory certifications, and strategic objectives for Peru. This session defines the exact research scope and ensures every deliverable is calibrated to your decision timeline.
You receive a written scope confirmation document within 48 hours of the intake call. This document lists the specific research questions, data sources, deliverable formats, and a week-by-week milestone schedule. Any adjustments are agreed before research begins, eliminating scope creep and ensuring budget certainty.
MINSA and EsSalud together account for the majority of medical device purchasing in Peru, with EsSalud alone managing a network of over 400 facilities. Winning public tenders requires understanding the specific technical specifications written into SIGA and SEACE procurement processes, which often favor brands with established local registration and after-sales service infrastructure.
All medical devices sold in Peru must hold a valid DIGEMID registration, a process that can take 12 to 24 months for Class III devices without experienced local support. DIGEMID has been modernizing its digital submission platform, but in-person follow-up and a qualified local technical representative remain essential for navigating the process efficiently.
Peru imports over 95 percent of its medical devices, primarily from the United States, Germany, China, and Brazil, creating a structurally open market for international manufacturers. The absence of significant domestic production means that competitive advantage is built on registration speed, distributor relationships, and after-sales service quality rather than local manufacturing cost.
Post-pandemic investment in diagnostic equipment, point-of-care testing, and telemedicine-enabling devices has accelerated in Peru, supported by government commitments to strengthen primary care infrastructure. International manufacturers in imaging, in-vitro diagnostics, and patient monitoring are finding increasing demand from both public networks and the expanding private clinic sector in Lima and secondary cities.
Every Market Intelligence engagement for Peru Medical Devices delivers eight structured modules, each designed to answer a specific decision question your leadership team will face.
Quantified total addressable market and serviceable addressable market for your specific device category, segmented by public and private sector and by major region.
A step-by-step guide to the DIGEMID registration process for your device class, including required documents, fees, timelines, and common rejection reasons to avoid.
Profiles of the top five to eight competitors active in your category, covering their registered products, distributor relationships, pricing, and market positioning.
A comparison of your existing certifications and technical documentation against DIGEMID requirements, with a prioritized list of gaps to close before filing.
A visual and data-driven mapping of demand concentration across Peru's regions, highlighting priority cities and healthcare facility clusters for initial market focus.
Detailed profiles of the leading medical device distributors in Peru, including their product portfolios, DIGEMID registration capabilities, financial standing, and known exclusivity arrangements.
Benchmark pricing data for comparable devices in public tender awards and private sector sales, plus an overview of EsSalud and MINSA reimbursement mechanisms relevant to your category.
Two to three entry strategy options with risk profiles, capital requirements, timeline estimates, and a recommended path forward based on your company's specific capabilities and objectives.
You manufacture medical devices outside Peru and are assessing whether the market justifies the investment in DIGEMID registration and local distribution. You need objective data on market size, regulatory cost, and competitive intensity before committing budget. Our intelligence gives your leadership team the evidence base to make a go or no-go decision with confidence.
Stop guessing and start deciding. Taevas Global delivers the regulatory, competitive, and commercial intelligence medical devices manufacturers need to enter Peru with precision and speed.